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Summary 
Erythroblastic islands  are anatomical units consisting of a central macrophage surrounded by 
erythroblasts. We studied the adhesion molecules involved in the formation of these structures. 
Central macrophages of erythroblastic islands isolated from the spleens of phlebotomized mice 
were dearly stained for vascular cell adhesion molecule 1 (VCAM-1). The surrounding erythroblasts 
of the erythroblastic islands  strongly expressed the a4 integrin of very late activation antigen 
4 (VLA-4:a4B1  integrin), the counter receptor of VCAM-1, whereas most reticulocytes and 
erythrocytes did not.  Both monoclonal antibodies (mAbs) against oe4 integrin and VCAM-1 
disrupted the erythroblastic islands cultured in the presence of erythropoietin. Moreover, adhesion 
of splenic erythroblasts to tumor necrosis factor a-stimulated mouse splenic endothelial cells, 
which showed high expression of VCAM-1 but not intercellular adhesion molecule 1, was inhibited 
by the anti-VCAM-1 and anti-a4 mAbs. These findings suggest that VLA-4-VCAM-1 interaction 
plays a crucial role in the formation of erythroblastic islands. 
B 
one marrow resident macrophages (MCFs) establish stroma 
by extending long cytoplasmic processes and attaching 
to developing erythroid and myeloid cells (1, 2). These cells 
are both phenotypica[ly and functionally different from peri- 
toneal M4's and monocytes (3, 4). In long-term bone marrow 
culture by which hematopoietic stem cells are maintained, 
immature myelomonocytic  cells are attached to and proliferate 
on the M~s defined by the mAb F4/80 (5).  The addition 
of erythropoietin to these cultures alternatively induces ery- 
thropoietic activity on the M~s, which form erythroblastic 
islands (EI) composed of central M~s and surrounding ery- 
throblasts (Ebs) (6, 7). These lines of evidence suggest that 
erythropoietin-responsive erythroid precursors adhere to the 
M~s, where they are induced to proliferate and differentiate 
into erythrocytes by maintaining contact with the central M~s. 
To gain insight to the possible function of the M~s in ery- 
thropoiesis,  we have considered it a priority to identify specific 
adhesion molecules involved in El formation (8). 
Recently, Morris et al. (9) characterized the nature of the 
adhesion using El isolated from fetal liver and found that 
the adhesion required divalent cations. Soligo et al. (10) demon- 
strated that a divalent cation-dependent adhesion molecule, 
very late activation antigen 4 (VLA-4) (a4B1) integrin, was 
present on Ebs, and that this molecule was localized at sites 
of intercellular contact between Ebs  and M~s  in human 
marrow, suggesting that VLA-4 might be involved in the 
adhesive interaction. The ligand of VLA-4 for cell-cell inter- 
action is vascular cell adhesion molecule I (VCAM-1), which 
was first identified on TNF-ce-stimulated human umbilical 
endothelial cells (11, 12).  Using the bone marrow stromal 
cell culture system, VCAM-1 has been shown to be constitu- 
tively expressed in stromal cells, and to be involved in B lym- 
phocyte-stromal cell (13) and hematopoietic stem cell-stromal 
cell interactions (14). However, morphological precise char- 
acterization of VCAM-l-positive cells in hematopoietic tissues 
has not yet been performed. In the present study, we showed 
that VCAM-1 was strongly expressed on central M~s in EI, 
and that the adhesive interaction between VLA-4 on Ebs and 
VCAM-1 on the central M~ plays an important role in the 
formation of EI. 
Materials and Methods 
Cells and Antibodies.  Bone  marrow  ceils were prepared by 
flushing the femora of 8-wk-old C3H/HeN mice (Charles River 
Japan Inc., Tokyo,,  Japan) using a syringe with a 26-gauge needle. 
Splenic Ebs were prepared from the spleens of anemic mice. Briefly, 
the mice were bled into heparinized capillary tubes from the retro- 
orbital sinus 3 d (0.5 ml) before killing. Mice were killed by cer- 
vical dislocation, and their spleens were excised, washed in RPMI 
1640 medium (GIBCO  BILL, Gaithersburg,  MD)  containing 
0.004% DNase (Sigma Chemical Co., St. Louis, MO), and minced 
in the medium with scissors. After passing the fragments through 
a syringe with a 26-gauge needle several times, the suspensions 
were settled for 5 rain and then the small amount of residual un- 
digested white tissue and cellular aggregates were discarded. The 
suspension was washed in cation-depleted PBS at 80 g for 3 min 
three  times and the supernatants containing  erythrocytes were 
discarded. The sedimented Ebs-rich fraction was resuspended in 
411  J. Exp.  Med.  ￿9  The Rockefeller  University Press ￿9 0022-1007/95/01/0411/05 $2.00 
Volume  181  January 1995  411-415 RPMI  1640 medium containing 0.2 U/ml human recombinant 
erythropoietin (EPOCH |  Chugai Pharmaceutical Ltd., Tokyo, 
Japan) and used for the adhesion assay. Peritoneal M~s were pre- 
pared as described  previously (2). A mouse splenic endothelial cell 
line (SPE-1) was established  and used for adhesion  assay  as described 
previously (15). Hybridoma cells, PS/2 (rat anti-mouse c~4 inte- 
grin mAb) (16), M/K-1 (rat anti-mouse VCAM-1 mAb) (13), and 
KM201 (rat anti-mouse CD44 mAb) (17) were obtained through 
the American Type Culture Collection (Rockville, MD). KAT-1 
(rat anti-mouse intercellular adhesion  molecule I [ICAM-1] mAb) 
(18) was purchased from Serotec Inc. (Oxford, UK). F10 (rat anti- 
Forssman glycosphingolipid  mAb) was produced as described  pre- 
viously  (19). Purified  mAbs (PS/2 and M/K-l) were kind gifts from 
Dr. Kensuke Miyake (Saga Medical School, Saga, Japan). 
Flow Cytometry.  For the study of VCAM-1, ICAM-1, and oL4 
expression on SPE-1 cells, the cells were treated with or without 
10 ng/ml mouse recombinant TNF-c~ (Boehringer Mannheim- 
Yamanouchi, Tokyo,  Japan) for 12 h and then detached from cul- 
ture flasks  using 0.1% EDTA. The cells were incubated for 20 min 
on ice with M/K-l, KAT-1, or PS/2 mAbs. After two washes in 
PBS containing 1% horse serum, the cells were incubated with 
PE-labeled anti-mouse goat F(ab')z IgG (Tago, Inc., Burlingame, 
CA) on ice for 20 min, washed, and analyzed by FACScan  | 
Isolation and Culture of  Mouse Splenic El.  E1 were isolated and 
enriched from the spleens of bled mice by collagenase digestion, 
unit gravity sedimentation, and PercoU  density gradient separation 
as described  previously  (19, 20). The El fraction containing 90.1% 
Ebs and 3.4% M~s was used for immunocytochemistry and inhi- 
bition tests. 
Imraunocytochemistry.  Acetone-fixed  cytospin  preparations of EI, 
bone marrow cells, and resident peritoneal Mq~s were stained with 
PS/2, M/K-l, KM201, and KAT-1 as described previously (2). 
Inhibition Test  on EI Forraation  by Use of  mAbs.  After suspending 
the  EI  fraction in  RPMI  1640 medium containing 0.2  U/ml 
erythropoietin, 150/~1 of the suspension was placed on a 35-mm 
plastic dish (Falcon, Oxnard,  CA) and incubated at 37~  in a 
CO2  incubator. 30  min  later, the  medium  was  decanted and 
loosely bound cells were removed by direct flushing with RPMI 
1640 medium. This treatment left EI bound on the surface  of the 
dish. The El were cultivated with RPMI 1640  medium containing 
0.2 U/ml human recombinant erythropoietin with antiadhesion 
molecule mAbs or 0.5 mg/ml of the peptide GPEILDVPST (se- 
quence containing the VLA-4-binding epitope spanning the CS-1 
fragment of fibronectin) (Pennisula Laboratories, Inc., Belmont, 
CA) (12) as inhibitors. 3 h later, the medium was decanted and 
loosely bound cells were removed by gentle flushing with RPMI 
1640 medium. The cultures were fixed in PBS containing 0.3% 
glutaraldehyde,  and the number of calls attached to the M~s were 
scored under a phase contrast microscope. 
CelIAdhesion Assay.  SPE-1  monohyers  were prepared  by seeding 
onto 35-mm dishes at 50,000 cells/well 3 d before the adhesion 
assay. Monolayers  were treated with or without 10 ng/ml TNF-c~ 
for 12 h. After SPE-1 cells were washed once with RPMI 1640 
medium and preincubated for 15 min at 4~  in 1 ml of RPMI me- 
dium with or without mAbs (KM201, KAT-1,  PS/2, and M/K-l), 
the mouse Ebs-rich fractions  were overhyed  on the SPE-1 monolay~ 
at a density of 3  x  106/dish in RPMI 1640 medium containing 
mAbs and incubated at 37~  for 20 min. Dishes were then rinsed 
with RPMI 1640 medium three times and fixed in 0.1 mol/liter 
phosphate buffer containing 2% paraformaldehyde  for 30 min. At- 
tached cells  were counted under the phase contrast microscope. In- 
hibition of adhesion was studied using mAbs KM201, PS/2, and 
M/K-1 each at concentrations  of 10/~g/ml. To identify  morphology 
of the cells attached to SPE-1 cells, the dishes were rinsed with 
cation-depleted PBS, and cells detached from the SPE-1 cells were 
collected and prepared for Giemsa staining. 
Results and Discussion 
Expression of  Adhesion Molecules in El.  EIs, a form of close 
association of M~s with Ebs, have been observed in humans 
and other mammals (6, 8). Crocker and Gordon (1) reported 
that central M~s in EI are positive for F4/80 antigen and 
are different from fibroblastic  stromal ceUs. Recent interest 
has been focused on the adhesion molecules involved in the 
formation of these structures (2, 3, 8). Thus, we first exam- 
ined the expression  of some adhesion molecules (VCAM-1, 
ICAM-1, CD44, and oe4 integrin) in EI isolated from anemic 
mouse spleen by coUagenase digestion. The central M~s in 
these structures were positive for VCAM-1, ICAM-1, and 
CD44 (Fig.  1, B-D), and some were weakly positive for oe4 
integrin. Surrounding Ebs in the El were clearly positive for 
ol4 and CD44 (Fig. 1, A  and D), whereas erythrocytes and 
reticulocytes were negative for oe4. The EI from mouse bone 
marrow showed the same staining reactions with these mAbs 
(data not shown). In contrast to central M~s of EI, no resi- 
dent peritoneal M~s were stained with anti-VCAM-1. 
Inhibitory Effects of raAbs against ~e4 Integrin and VCAM-1 
on El Formation in vitro  To examine the possible  function 
of VCAM-1 in the formation of El, we used the short-term 
culture system of splenic EI that we reported previously (20). 
Splenic El cultured in the presence of erythropoietin remained 
intact for a short period. Characteristically, Ebs showed gra- 
diental arrangement on the surface of central M~s;  more 
differentiated Ebs and enudeated cells were seen at the pe- 
riphery. In the absence of erythropoietin, erythropoietic ac- 
tivity completely disappeared within 24 h, and grantdocytic 
calls were found in some isolated EI. 
3 h after the addition of anti-VCAM-1 (M/K-l) or anti- 
oe4 integrin (PS/2) mAbs to the EI cultures, Ebs became at- 
Figure 1.  Immunoeytoc.hemical  localization  of  or4 integrin  (A), VCAM-1 
(B), ICAM-1 (C), and CD44 (D) in EI isolated  from mouse spleen. (*) 
Central  M~s. (Arrow)  A cytoplasmic  process of  the centaal  M~. Bar, 13 #m. 
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ment. Gentle flushing of the medium using Pasteur pipettes 
easily destroyed the El structure, although some El were resis- 
tant to the treatment (Fig.  2, B and C). On the other hand, 
anti-CD44 (KM201), anfi-ICAM-1 (KAT-1), or anti-Forssman 
glycosphingolipid (F10) mAbs had hardly any effect on the 
El structure (Fig.  2, D-F). Quantified effects of the various 
mAbs on El in these cultures are shown in Table 1. These 
results support the possibility that Ebs are capable of attaching 
to the central  MCI,  s via VLA-4-VCAM-1  interaction. 
VLA-4 also functions by binding to the CS-1 domain of 
fibronectin  (12).  Therefore,  we tested CS-1 peptide in the 
El culture system, but this peptide had no effects on El for- 
mation (data not shown). This is consistent with the previ- 
ously reported observation that fibronectin, RGD-containing 
peptides,  and specific antisera  against  the fibronectin receptor, 
had  no effects on El  formation  in  vitro  (9). 
Adhesion of Erythroblasts to TNF~-stimulated SECs.  To 
confirm the involvement of VLA-4-VCAM-1 interaction in 
El formation, we used another adhesion assay system to test 
adhesion  of Ebs to the SPE-1  established from mouse pri- 
mary splenic culture and characterized by typical endothelial 
cell morphology distinct  from those of fibroblasts, smooth 
muscle cells,  and M~s.  These cells  take up acetylated low 
density lipopmtein, react with antibodies against an endothelial 
call-specific antigen (Meca 99) and against basement mem- 
brane proteins, and are stained by fluorescein-labeled Griffonia 
simplicifolia  lectin known to stain mouse endothelial cells (15). 
Upon examination of the expression of VCAM-1, ICAM-1, 
and ce4 integrin on nontreated and TNF-ol-stimulated SPE-1 
cells by flow cytometry, it was found that TNF-ce stimula- 
tion greatly induced only VCAM-1 expression on SPE-1 cells. 
Figure 2.  Effects  of mAbs on maintenance of El in culture in the pres- 
ence  of erythropoietin. (.4) Control; (B) anti-or4  integrin; (C) anti-VCAM-1; 
(D) anti-lCAM-1; (E) anti-CD 44; and (F) anti-Forssman  glycosphingolipid. 
Bar, 48/~m. 
Table  1.  Quantitative  Effects of mAbs on El Cultured in  the 
Presence of Erythropoietin 
mAb 
(Specificity)  Dose  Number of Ebs/M4~ 
/~g 
No Ab  23  _+  9* 
M/K-1  (VCAM-1)  5  6  +_  6* 
M/K-1  10  5  _+  6~ 
PS/2 (c~4 integrin)  5  10  _+  7t 
PS/2  10  7  _+  6* 
M/K-1  +  PS/2  5  +  5  5  _+  5* 
KAT-1  (ICAM-1)  10  22  _+  9 
KM201  (CD44)  5  23  _+  10 
F10 (Forssman GSL)  10  20  +_  8 
El from anemic mouse spleen were placed on 35-ram dishes and incubated 
in RPMI 1640 cont=ining 0.2 U/ml erythropoietin and mAbs. 3 h later, 
the dishes were gently flushed of the culture medium, fixed in 0.3% gh- 
taraldehyde,  and observed under the phase contrast  microscope. 
* Data are shown as the mean +  SD (n  =  50) of the total number of 
Ebs attached  to an underlying M~. 
t p  <0.01  co~pared with the control (no Ab) by Student's t-test. 
Neither  nonstimulated  nor TNF-ce-stimulated  SPE-1 cells 
were stained for ICAM-1 (Fig.  3). In the adhesion assays of 
Ebs obtained from phlebotomized mouse spleen, the Ebs ad- 
hered strongly to TNF-ce-stimulated SPE-1 cells but not to 
a4 
4=0 
VCAM-I 
480 
ICAM-1 
Log Fluorescence 
Figure 3.  Flow cytometric an- 
alysis  of the expression  ofce4 inte- 
grin (top), VCAM-1 (m/ddk), and 
ICAM-1  (bottom) in  nontreated 
(  ......  ) and TNF-c~-stimuhted 
(  )  SPE-1 cells. Control 
staining (  ......  ) was performed 
without  primary Ab.  104  cells 
in each group were analyzed by 
FACScan  |  Histograms plotted as 
cell number  vs log fluorescence  in- 
tensity. Some unstimulated cells 
were positive for VCAM-1, and 
TNF-ce stimulation significantly 
increased VCAM-1 expression. 
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and Splenic Ebs to SPE-1 Cells 
Treatment 
TNF-c~  Ab (10/~g/ml)  Bone marrow cells  Splenic  Ebs 
-  -  9  _+  2"  17  •  7 
-  M/K-1 (VCAM-1)  8  -+  4  ND 
+  -  73  •  36  164  •  33 
+  M/K-1  17  •  4*  12  _+  5* 
+  PS-2 (o~4 integrin)  7  •  4t  4  •  2t 
+  KAT-1 (ICAM-1)  76  _+  17  165  •  37 
~ Each number represents mean •  SD (n -  4) of total number of cells 
attached to 20 SPE-1 cells in different  incubation dishes. Bone marrow 
cells and splenic Ebs prepared as described  in Materials and Methods were 
incubated at 37~  with unstimulated or 12-h TNF-c~-stimulated  SPE-1 
cells in 35-ram dishes. Adhesion of Ebs to SPE-1 cells was quantified  by 
counting adherent cells under the phase contrast microscope  at 20 SPE-1 
ceils per incubation dish. 
*  p <0.01 compared  with the control (TNF-c~ +  no Ab) by Student's 
t-test. 
nonstimulated SPE-1 cells. This adhesion was completely in- 
hibited by anti-VCAM-1 and anti-c~4 mAbs but not by anti- 
CD44,  or anti-ICAM-1  mAbs,  as shown in Table 2. 
o~4 integrin has been shown to be distributed on a variety 
of types of hematopoietic cells including hematopoietic stem 
cells, lymphocytes, Ebs, monocytes, and immature granulo- 
cytes (10, 14, 16). We confirmed this by morphological  study 
of bone marrow cells attached to TNF-ot-stimulated SPE-1 
cells  that  showed strong expression of VCAM-1  but  not 
ICAM-1 (Table 2). These findings suggested the possibility 
that several types of hematopoietic cell islands might be formed 
via VLA-4-VCAM-1 interaction. In vivo, however, complete 
rosettelike structures were observed only in Ebs-M~s adhe- 
sion (namdy El), but not in myelomonocytic cell-M6s or 
lymphocyte-M~s adhesions. This suggests that not only VLA- 
4-VCAM-1 interaction but also some unknown adhesion mol- 
ecules or unknown factors might be involved in the forma- 
tion of EI in vivo. 
The present results raise intriguing questions about the 
biological significance of the VLA-4-VCAM-1 interaction of 
El. In this regard, the following possible functions of El have 
been speculated (3, 8):  (a) The Ebs-MCI, contact may serve 
to allow rapid expansion of Ebs; (b) The contact may pro- 
mote Ebs enudeation in the same fashion as the Ebs-fibronectin 
interaction (21); and (c) The Ebs-M~ adhesion may regulate 
the release of reticulocytes from hematopoietic tissues. In ad- 
dition, considering the recent finding that VLA-4-u 
interaction in follicular dendritic cell-B cell clusters serve to 
inhibit apoptosis of germinal center B ceils (22), it may also 
be possible that the central Mcl, may play a supportive role 
in erythropoiesis by inhibiting apoptosis of Ebs through the 
VLA-4-VCAM-1  interaction. 
In conclusion, the present results indicate that attention 
should be paid to the resident MCI,  s as well as stromal cells 
to understand the in vivo mechanisms underlying hemato- 
poiesis. 
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